Latest updates for Precision Oncology

Fresh curated links around precision oncology are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Behind the outcomes: How whole-patient support is reshaping oncology care
  • The Emerging Power of Mass Spectrometry in Oncology
  • AI Learns to Predict Patient Outcomes Even When Key Omics Data Are Missing

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

biopharmadive.com /1 month ago

Behind the outcomes: How whole-patient support is reshaping oncology care

As oncology care grows personalized and home-based, support around treatment becomes as vital as treatment.

Read source
genengnews.com /1 month ago

The Emerging Power of Mass Spectrometry in Oncology

Novel approaches are urgently needed to improve availability of diagnostic assays, and recent efforts have shifted toward uncovering the biological pathways and molecular profiles...

Read source
bioengineer.org /1 month ago

AI Learns to Predict Patient Outcomes Even When Key Omics Data Are Missing

Precision medicine has long promised a future in which a patient’s treatment is tailored to the molecular signatures written into their genome, transcriptome, epigenome, proteome a...

Read source
fiercehealthcare.com /1 month ago

OpenEvidence deepens oncology push to build specialized AI agents, launches new AI model family

The partnership builds on OpenEvidence's vision to develop “medical super-intelligence” based on agentic artificial intelligence, or a system of AI agents that can be subspecialist...

Read source
rna-seqblog.com /2 weeks ago

Boehringer taps Envisagenics’ AI to mine RNA splicing for cancer targets

RNA sequencing and AI help identify tumor-specific alternative splicing events that may reveal new precision oncology targets across solid tumors...

Read source
bioengineer.org /3 weeks ago

AI Tells Doctors When It Is Unsure About Cancer Treatment Success

Predicting whether a cancer patient will respond to therapy has long been one of oncology’s most consequential gambles. For people with metastatic non-small cell lung cancer, the m...

Read source
letlifehappen.com /1 month ago

Breast Cancer Brain Metastases Harbor Actionable Genomic Alterations: Could the Brain Lesion Become a Precision-Oncology...

From: oncodaily.com Brain metastases remain one of the most difficult complications of metastatic breast cancer. Approximately 30% of patients with metastatic disease will eventual...

Read source
genengnews.com /1 day ago

Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinatio...

Read source
journals.plos.org /1 month ago

Biomarker discovery and patient stratification in pancreatic cancer using incomplete multi-omics data

by Alejandra Paja-García, Rafael Romero-Becerra, Tero Aittokallio, Alberto López Pancreatic ductal adenocarcinoma (PDAC), with a 12% 5-year survival rate, is the most aggressive t...

Read source
biopharmadive.com /2 weeks ago

Precision for All: Closing the gap between innovation and impact

Why diagnostic-driven therapies need a new commercialization model to reach more eligible patients.

Read source
medcitynews.com /1 month ago

Innovation in Oncology: The Synergy of New and Old Drugs

Years of joint industry-academic engineering suggest that highly engineered single agents will not be the most effective treatments for solid tumors; the solution will be combining...

Read source
kevinmd.com /2 weeks ago

Biomarker testing can find the mutation driving your cancer

“What was cancer, Grandpa?” These were words I hoped to hear from my grandchildren. As a practicing physician for over forty-five years, I wasn’t sure whether futuristic care would...

Read source
snowflake.com /1 week ago

From Discovery to Remission: How Agentic AI Is Reshaping the Oncology Continuum

Agentic AI is closing oncology's data gaps — from drug discovery to survivorship. See how AI agents in healthcare are reshaping cancer care today.

Read source
qchron.com /6 days ago

Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congres...

First Phase 1 data for sofetabart mipitecan, Lilly's investigational FRО±-targeting ADC, in platinum-sensitive ovarian cancer to be featured in a rapid oral presentation

Read source
labiotech.eu /3 days ago

Oncology biotech news: key moves to watch in October 2026 

Delve into Labiotech's October oncology roundup and find out about the news that caught our attention this last month. The post Oncology biotech news: key moves to watch in October...

Read source
academyhealth.org /1 month ago

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale For patients facing uncertainty or fear around a cancer diagnosis, cancer biomarker...

Read source
genengnews.com /1 month ago

Precure Selects Helix as Multiomics Lab and AI Tools Provider

Mayo Clinic recently launched Precure with founding partner Thermo Fisher Scientific to help transform how the life sciences community understands the biological changes that occur...

Read source
newscientist.com /1 week ago

A revolutionary way of targeting tumours could beat even the worst cancers 

We have long treated cancer based on its location in the body. But a whole new approach that analyses tumours differently is now helping people survive forms of cancer that were on...

Read source
genengnews.com /2 weeks ago

The Epitranscriptome Heads Toward Clinical Necessity

Short-read RNA sequencing reporting the modifications that alter protein output is starting to make epitranscriptomics indispensable for patient selection in precision medicines. T...

Read source
prweb.com /1 month ago

OncoLens' AI-Powered Analytics Platform Helps Large Academic Cancer Center in Florida Cut Referral Delays and Surface Ca...

Case study finds nearly 9 in 10 actionable cancer data points existed only in unstructured text invisible to standard EMR reporting; OncoLens Analytics helped the center lift on-ti...

Read source
rna-seqblog.com /2 weeks ago

Urine test may improve bladder cancer diagnosis and guide treatment decisions

RNA sequencing of urine cell-free RNA can detect bladder cancer, monitor residual disease and help predict whether patients may respond better to immunotherapy or chemotherapy...

Read source
pharmexec.com /2 weeks ago

<![CDATA[The Future of Precision Medicine Depends on More Than Biology]]>

Read source
singularityhub.com /1 month ago

A Digital Cell Predicts Which Drugs Will Be Most Effective in Deadly Breast Cancer

The AI-powered virtual cell tailors treatments for breast cancer based on samples of each patient's tumor. The post A Digital Cell Predicts Which Drugs Will Be Most Effective in De...

Read source
labiotech.eu /1 month ago

How AOCs are advancing targeted therapeutics

The concept of targeted therapeutics is often traced back to German Nobel laureate Paul Ehrlich’s “magic bullet” in 1907, which envisioned a single entity that could both recognize...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Precision Oncology

academyhealth.org

Recent coverage from public sources
Public source

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

journals.plos.org

Recent coverage from public sources
Public source